30 inmates file lawsuit against PA prison: Prepare for a wave of MRSA litigation
Today's Financial News - Posted January 28, 2009
Thirty current and former inmates just filed a class-action lawsuit, claiming their Pennsylvania penitentiary infected them with MRSA. There’s hundreds of millions of dollars waiting to be made in MRSA litigation. And one company will reap the benefits.
by J. Christoph Amberger
Baltimore—TFN: Our timing couldn’t have been more accurate. Just two weeks ago, we published a special report on TFN called “This drug-resistant “superbug” could be the biggest source of “Jackpot Justice” since asbestos litigation.”
In it, I quoted Dr. Betsy McCaughey, a former Lieutenant Governor of New York State and Founder/Chairman of the Committee to Reduce Infection Deaths, who released a handbook on combating hospital-acquired infections back in October.
“Hospital infection is the next asbestos, the next major cause of class action lawsuits, and the compendium will be the trial lawyer’s bible,” Dr. McCaughey said.
Hospitals that fail to adhere to its guidelines are vulnerable to legal action… and could end up paying huge damage awards.
It’s starting already: The media reported just this morning that a full thirty former and current inmates of Northampton County Prison in northeastern Pennsylvania just filed suit in Federal court. Their beef: They contracted a methicillin-resistant Staphylococcus aureus, MRSA, due to the conditions in the prison and lack of appropriate treatment.
Prison officials in 2005 did indeed confirm a MRSA outbreak in the prison. Two former inmates already won a $1.2 million jury award in a MRSA-related suit.
This is the beginning of class-action MRSA litigation… a potential gold mine for litigation lawyers running out of viable asbestos, tobacco, and mold torts.
After prisons, it will be hospitals, healthclubs, school systems, universities, and healthcare providers all over the country who need to prepare for a wave of lawsuits—because a large percentage of the U.S. publication is already colonized with this “superbug”… and the bacterium can be acquired by shaking hands, sharing a towel, or touching a light switch.
There’s one company we discovered that stands to make a killing when the litigation frenzy begins! In fact, early investors could see gains of as much as 250%—no matter what the economy is doing! Right now, the market has created an excellent window of opportunity to get in on this fast-moving stock before its next earnings report in late February.
But you be the judge of it: Check out our Special Report, Jackpot Justice: Make Triple-Digit Gains On Superbug Litigation.
Next Article: Dredging up profits
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down